- Report
- June 2020
- 228 Pages
Global
From €3384EUR$3,500USD£2,906GBP
- Report
- December 2021
- 330 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- August 2021
- 214 Pages
Global
From €4036EUR$4,175USD£3,467GBP
- Report
- April 2024
- 138 Pages
Global
From €3770EUR$3,899USD£3,238GBP
- Report
- April 2024
- 136 Pages
Global
From €3770EUR$3,899USD£3,238GBP
- Report
- July 2022
- 201 Pages
Global
From €4689EUR$4,850USD£4,028GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- October 2021
- 102 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- April 2023
- 110 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- April 2023
- 115 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- April 2020
Europe
From €8696EUR$8,995USD£7,470GBP
- Report
- January 2020
United States
From €7729EUR$7,995USD£6,639GBP
- Report
- March 2018
United States
From €4346EUR$4,495USD£3,733GBP
- Report
- January 2023
- 115 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- January 2023
- 118 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- July 2021
- 114 Pages
Global
From €4302EUR$4,450USD£3,695GBP
- Report
- August 2018
- 115 Pages
Global
From €4544EUR$4,700USD£3,903GBP
- Report
- February 2018
- 68 Pages
Global
From €3577EUR$3,700USD£3,073GBP
- Report
- January 2022
Global
From €7251EUR$7,500USD£6,228GBP
The Vena Cava Filter market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to prevent pulmonary embolism, a condition in which a blood clot travels to the lungs. Vena Cava Filters are inserted into the inferior vena cava, the largest vein in the body, to capture and prevent the clot from reaching the lungs. The filters are typically made of stainless steel and are designed to be retrievable, allowing for removal once the risk of pulmonary embolism has passed.
The Vena Cava Filter market is driven by the increasing prevalence of deep vein thrombosis, a condition in which a blood clot forms in the deep veins of the body. This is often caused by prolonged immobility, such as during long-distance travel or hospitalization. The market is also driven by the increasing number of minimally invasive procedures, such as laparoscopic surgery, which require the use of Vena Cava Filters.
Notable companies in the Vena Cava Filter market include Boston Scientific, Cook Medical, and Cordis Corporation. Show Less Read more